Health Condition 1: M751- Rotator cuff tear or rupture, notspecified as traumatic
Conditions
Interventions
Intervention1: Platelet rich plasma injection: ultrasonography guided injection of 2-3 ml PRP at the site of tear in grade II rotator cuff tear
Control Intervention1: Dextrose injection (12.5%): ultra
Sponsors
ESI Institute of Pain Management
Eligibility
Inclusion criteria
Inclusion criteria: 1) Refractory to 2 month conservative treatment 2) Diagnosis confirmed by MRI
Exclusion criteria
Exclusion criteria: 1) Patient refusal. 2) Bleeding diathesis and preoperative platelet count <125,000 or less likely 3) RC tears secondary to fracture and dislocations, patients with an associated dislocation at the time of study 4) RC tears that underwent prior surgical repair or revision arthroscopy 5) preexisting conditions associated with upper extremity pain, including impingement, arthritis, ongoing infection, carpal tunnel syndrome, cervical neuropathy, other nerve pathologies, local malignancy, and systemic disorders (uncontrolled diabetes, hypothyroidism), gross shoulder instability. 6) problems with follow-up and patients in another on-going trial that would interference with the assessment of the primary or secondary outcomes
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain in Numeric Rating ScaleTimepoint: Before injection, After 8 weeks and 12 weeks of injection | — |
Secondary
| Measure | Time frame |
|---|---|
| Quality of Life assessed by University of California at Los Angeles Shoulder scale (UCLA)Timepoint: Before injection, After 8 weeks and 12 weeks of injection | — |
Countries
India
Contacts
Public ContactDr Subrata Goswami
ESI Institute of Pain Management
Outcome results
None listed